Lack of association of OPRM1 genotype and smoking cessation.

Lack of association of OPRM1 genotype and smoking cessation.

<p>INTRODUCTION: Previous studies have reported an association between μ-opioid receptor (OPRM1) genotype and smoking cessation, with some evidence that the strength of this association depends on dose of nicotine replacement therapy (NRT). We examined whether a single-nucleotide polymorphism...

Bibliografski detalji
Glavni autori:	Munafò, MR, Johnstone, E, Aveyard, P, Marteau, T
Daljnji autori:	Society for Research on Nicotine and Tobacco
Format:	Journal article
Jezik:	English
Izdano:	Oxford University Press 2013

Slični predmeti

Association of COMT Val108/158Met genotype with smoking cessation.
od: Munafò, MR, i dr.
Izdano: (2008)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
od: Munafò, MR, i dr.
Izdano: (2009)

CHRNA3 rs1051730 genotype and short-term smoking cessation.
od: Munafò, MR, i dr.
Izdano: (2011)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
od: Munafo, M, i dr.
Izdano: (2009)

Smoking cessation, weight gain, and DRD4 -521 genotype
od: Munafò, MR, i dr.
Izdano: (2006)

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
od: Spruell, T, i dr.
Izdano: (2012)

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
od: David, S, i dr.
Izdano: (2011)

Association of the mu-opioid receptor gene with smoking cessation.
od: Munafò, MR, i dr.
Izdano: (2007)

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
od: Johnstone, E, i dr.
Izdano: (2007)

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
od: Uhl, G, i dr.
Izdano: (2010)

Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: Abstinence and withdrawal symptoms
od: Munafo, MR, i dr.
Izdano: (2007)

Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.
od: Aveyard, P, i dr.
Izdano: (2007)

Interventions for smoking cessation in hospitalised patients
od: Rigotti, NA, i dr.
Izdano: (2002)

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
od: David, S, i dr.
Izdano: (2008)

Erratum: Genome-wide association for smoking cessation success: Participants in the Patch in Practice trial of nicotine replacement (Pharmacogenomics (2010) 11:3 (357-367))
od: Uhl, G, i dr.
Izdano: (2010)

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.
od: Welton, N, i dr.
Izdano: (2008)

Smoking cessation 4: Antidepressants for smoking cessation - Bupropion and nortriptyline
od: Aveyard, P, i dr.
Izdano: (2010)

Smoking reduction interventions for smoking cessation
od: Lindson, N, i dr.
Izdano: (2018)

Managing smoking cessation.
od: Aveyard, P, i dr.
Izdano: (2007)

Drugs for smoking cessation
od: Hartmann-Boyce, J, i dr.
Izdano: (2016)

Interventions for smoking cessation in hospitalised patients
od: Rigotti, NA, i dr.
Izdano: (2012)

Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study.
od: McDermott, MS, i dr.
Izdano: (2013)

Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
od: Aveyard, P, i dr.
Izdano: (2009)

Financial incentives for smoking cessation in pregnancy: protocol for a single arm intervention study.
od: Marteau, T, i dr.
Izdano: (2013)

Addressing concerns about smoking cessation and mental health: Theoretical review and practical guide for healthcare professionals
od: Taylor, GMJ, i dr.
Izdano: (2020)

The place of varenicline in smoking cessation treatment.
od: Aveyard, P
Izdano: (2008)

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
od: Munafò, MR, i dr.
Izdano: (2008)

Smoking reduction interventions for smoking cessation
od: Lindson, N, i dr.
Izdano: (2019)

Genes and cigarette smoking.
od: Munafò, MR, i dr.
Izdano: (2008)

Lack of attentional retraining effects in cigarette smokers attempting cessation: A proof of concept double-blind randomised controlled trial
od: Begh, R, i dr.
Izdano: (2015)

Smoking cessation interventions for hospitalized smokers: a systematic review.
od: Rigotti, N, i dr.
Izdano: (2008)

Electronic cigarettes for smoking cessation
od: Hartmann-Boyce, J, i dr.
Izdano: (2018)

Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.
od: Hollands, G, i dr.
Izdano: (2013)

Investigating subgroups in smoking cessation treatment response: Response to Perkins
od: Munafo, MR, i dr.
Izdano: (2004)

Motivational interviewing for smoking cessation
od: Lindson, N, i dr.
Izdano: (2019)

Future orientation and smoking cessation: secondary analysis of data from a smoking cessation trial.
od: Beenstock, J, i dr.
Izdano: (2014)

Improving smoking cessation approaches at the individual level.
od: Aveyard, P, i dr.
Izdano: (2012)

Smoking cessation 1: Choosing the right pharmacotherapy for each patient
od: Aveyard, P, i dr.
Izdano: (2009)

Managing smoking cessation Authors’ reply to letter
od: Aveyard, P, i dr.
Izdano: (2007)

Association of OPRM1 with addiction: a review on drug, alcohol and smoking addiction in worldwide population
od: Vanlal Hriatpuii, i dr.
Izdano: (2022-03-01)